Miromatrix Medical Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Miromatrix Medical's estimated annual revenue is currently $16.9M per year.(i)
  • Miromatrix Medical's estimated revenue per employee is $155,000

Employee Data

  • Miromatrix Medical has 109 Employees.(i)
  • Miromatrix Medical grew their employee count by -5% last year.

Miromatrix Medical's People

NameTitleEmail/Phone
1
Sr. Director QualityReveal Email/Phone
2
Purchasing ManagerReveal Email/Phone
3
Senior Clinical Affairs ManagerReveal Email/Phone
4
Manager - Cell Development & CharacterizationReveal Email/Phone
5
R&D Project ManagerReveal Email/Phone
6
Senior Manager, Project Management Office (PMO)Reveal Email/Phone
7
Manager Organ Recellurization, Miromatrix Medical Inc, Subsidiary United TherapeuticsReveal Email/Phone
8
Cell Manufacturing Technician 3Reveal Email/Phone
9
Senior ScientistReveal Email/Phone
10
Associate ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$9.3M6020%N/AN/A
#2
$9.1M59-34%N/AN/A
#3
$1.1M717%N/AN/A
#4
$0.3M2-93%N/AN/A
#5
$4.3M284%N/AN/A
#6
$1.4M950%N/AN/A
#7
$6M393%N/AN/A
#8
$15.8M1027%N/AN/A
#9
$18M1160%$20.5MN/A
#10
$34.1M17613%$39.1MN/A
Add Company

What Is Miromatrix Medical?

Miromatrix is a biotechnology company engaged in the development of fully biological human organs to solve the chronic shortage of transplantable organs, utilizing its patented perfusion decellularization/recellularization technology, as well as organ-derived biological products for applications such as soft tissue reinforcement and advanced wound care.

keywords:N/A

N/A

Total Funding

109

Number of Employees

$16.9M

Revenue (est)

-5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Miromatrix Medical News

2022-04-17 - Miromatrix CEO Jeff Ross to Present at the 2022 Cell & Gene ...

EDEN PRAIRIE, Minn., April 19, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel...

2022-04-06 - Miromatrix Medical Inc. (NASDAQ:MIRO) Short Interest Update

Miromatrix Medical Inc engages in the development of biological human organs to solve the chronic shortage of transplantable organs. The company...

2022-03-30 - Miromatrix Reports Fourth Quarter and Full Year 2021 Results ...

EDEN PRAIRIE, Minn., March 30, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$35M10928%N/A
#2
$16M1103%N/A
#3
$23.7M11310%N/A
#4
$26.3M116-4%N/A
#5
$18M1166%N/A